Notes - Significant Accounting Policies For Preparation Of Consolidated Financial Statements

Mochida Pharmaceutical Co.,Ltd. - Filing #7724433

Concept As at
2018-03-31
2017-04-01 to
2018-03-31
Notes - Significant accounting policies for preparation of consolidated financial statements
Notes - Significant accounting policies for preparation of consolidated financial statements
Disclosure of scope of consolidation
Number of consolidated subsidiaries and names of major consolidated subsidiaries

1.連結の範囲に関する事項

当社の子会社は5社で全て連結しております。連結子会社名は、「第1 企業の概況 4.関係会社の状況」に記載のとおりであります。

 

Number of consolidated subsidiaries
5 xbrli:pure
Disclosure about fiscal years, etc. of consolidated subsidiaries

3.連結子会社の事業年度等に関する事項

連結子会社の事業年度の末日は、連結決算日と一致しております。

 

Talk to a Data Expert

Have a question? We'll get back to you promptly.